NVAX

Novavax Inc

$8.14

0.18 (2.26%) Today

— up— down

Compare NVAX

Market Cap

$1.31B-8.0%

Revenue (TTM)

$413.45M-61.6%

Net Income (TTM)

$-252,530,508

EPS (TTM)

-1.54

Shares Out

164.44M

P/E Ratio

2.98

Open

$8.01

Previous Close

$7.96

Day Range

$7.92 – $8.23

52-Week Range

$6.20 – $11.97

Beta

2.52

Earnings Date

Nov 4, 2026

Volume

3.46M

Avg Volume

4.28M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About NVAX

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.